CDC ACIP Unanimously Votes to Provisionally Recommend Merck's VAXNEUVANCE in Series with PNEUMOVAX ® 23 as an Option for Pneumococcal Vaccination in Appropriate Adults Pharmaceutical Investing
Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA Medical Device Investing
Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer's PREVNAR 20 in Adults Pharmaceutical Investing
Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance Medical Device Investing
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained Biotech Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, EAR, HYZN and SAVA Biotech Investing
Merck Issues Voluntary Nationwide Recall of CUBICIN® 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles Pharmaceutical Investing
Jamieson Wellness Inc. Announces Date of Third Quarter 2021 Financial Results and Conference Call Pharmaceutical Investing
